You are here

Long COVID

Axcella granted patent for long COVID fatigue treatment

Axcella granted patent for long COVID fatigue treatment

Medical Marketing and Media

Axcella Therapeutics

Flag link:

Study mapping how SARS-CoV-2 disrupts mitochondria suggests a cause for long Covid

Study mapping how SARS-CoV-2 disrupts mitochondria suggests a cause for long Covid

Stat

Flag link:

US to test Paxlovid as long COVID-19 therapy

US to test Paxlovid as long COVID-19 therapy

Beckers Hospital Review

clinical trials

Flag link:

NIH begins long-delayed clinical trials for long Covid, announces new research office

NIH begins long-delayed clinical trials for long Covid, announces new research office

Stat

clinical trials

Flag link:

New Yale study evaluates PAXLOVID's use in Long COVID recovery

New Yale study evaluates PAXLOVID's use in Long COVID recovery

Drugs.com

clinical trials

Flag link:

'We beg you': Biotechs plead for help and funds to find long COVID treatments

'We beg you': Biotechs plead for help and funds to find long COVID treatments

Fierce Biotech

Flagship Pioneering

Flag link:

Axcella Clears Regulatory Path for Long COVID Therapeutic

Axcella Clears Regulatory Path for Long COVID Therapeutic

BioSpace

Axcella Therapeutics

Flag link:

Axcella axes NASH program, 85% of staff in last-ditch focus on long COVID

Axcella axes NASH program, 85% of staff in last-ditch focus on long COVID

Fierce Biotech

Axcella Therapeutics

Flag link:

Researchers Are Studying Whether Paxlovid Can Treat Long COVID

Researchers Are Studying Whether Paxlovid Can Treat Long COVID

Time

Flag link:

Vaccinated people up to 80% less likely to have long COVID-19: study

Vaccinated people up to 80% less likely to have long COVID-19: study

Beckers Hospital Review

Flag link:

A long Covid collaborative kicks off with $15M to study causes of lingering disease, conduct clinical trials

A long Covid collaborative kicks off with $15M to study causes of lingering disease, conduct clinical trials

Endpoints

Dr. Patrick Soon-Shiong

Flag link:

Axcella previews long Covid registrational trial plans in UK and US

Axcella previews long Covid registrational trial plans in UK and US

Clinical Trials Arena

clinical trials

Flag link:

Long COVID Evidence Begins to Mount, Suggesting Biomarkers and a "Triangle" Effect

Long COVID Evidence Begins to Mount, Suggesting Biomarkers and a "Triangle" Effect

BioSpace

Flag link:

Axcella's CEO knows people are tired of the pandemic. But long COVID patients need help, too

Axcella's CEO knows people are tired of the pandemic. But long COVID patients need help, too

Fierce Biotech

Flag link:

Large UK study suggests vaccination helps treat long COVID

Large UK study suggests vaccination helps treat long COVID

Pharmaforum

Flag link:

Could Pfizer's Paxlovid or other antivirals help cure long COVID?

Could Pfizer's Paxlovid or other antivirals help cure long COVID?

Fierce Pharma

Flag link:

Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms

Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms

Endpoints

Vir Biotechnology

Atea Pharmaceuticals

Flag link:

Evidence grows that vaccines lower the risk of getting long COVID

Evidence grows that vaccines lower the risk of getting long COVID

NPR

Flag link:

New Evidence Suggests COVID-19 Vaccines Might Mitigate Long COVID

New Evidence Suggests COVID-19 Vaccines Might Mitigate Long COVID

BioSpace

Flag link:

Vaccination reduces risk of long Covid, even when people are infected, U.K. study indicates

Vaccination reduces risk of long Covid, even when people are infected, U.K. study indicates

Stat

Flag link:

Pages